Cause of death, by non-communicable diseases, ages 5-14, female in Libya
Libya: Cause of death, by non-communicable diseases, ages 5-14, female was 50.9% in 2021. ▼ Falling
Cause of death, by non-communicable diseases, ages 5-14, female in Libya, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 5-14.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 5-14, female in Libya stood at 50.9%.
Compared with earlier readings it is up 61.8% on the previous year and down 1.0% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 5-14, female in Libya peaked at 51.5% in 2010 and was at its lowest, 13.9%, in 2015.
That places Libya 60th out of 184 countries with data for 2021, putting it in the middle of the range.
Cause of death, by non-communicable diseases, ages 5-14, female in Libya, year by year
| Year | % of total female deaths ages 5-14 | Change |
|---|---|---|
| 2000 | 50.4% | — |
| 2010 | 51.5% | +2.1% |
| 2015 | 13.9% | -73.0% |
| 2019 | 26.4% | +89.7% |
| 2020 | 31.5% | +19.4% |
| 2021 | 50.9% | +61.8% |
Libya compared with similar countries
- Libya's 50.9% is above the median for upper middle income countries, which is 39.9%, 1.3× the median. (55 countries reporting)
- Libya's 50.9% is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 47.1%, 1.1× the median. (23 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 50.4% | 50.4% | 50.4% | 1 |
| 2010s | 30.6% | 13.9% | 51.5% | 3 |
| 2020s | 41.2% | 31.5% | 50.9% | 2 |
Countries ranked near Libya
More health data for Libya
- Un projection of annual infant deaths, annual growth rate -1.48 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.1 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,084 deaths per 1,000 people (2090)
- Number of infants who die before age 1 133 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2024)
- Population ages 00-04, female, annual growth rate -1.83 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0404 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.77 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 5-14, female in Libya?
- Cause of death, by non-communicable diseases, ages 5-14, female in Libya was 50.9% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 5-14, female recorded in Libya?
- The highest recorded value was 51.5% in 2010.
- What is the lowest cause of death, by non-communicable diseases, ages 5-14, female recorded in Libya?
- The lowest recorded value was 13.9% in 2015.
- How does Libya rank for cause of death, by non-communicable diseases, ages 5-14, female?
- Libya ranks 60th out of 184 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 5-14, female rising or falling in Libya?
- Over the last ten years it is down 1.0%. The long-run trend across the full record is falling.
- Where does this Libya data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.